SEC Form 4 · accession 0000911916-17-000040
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Dvorak
Officer — President and CEO · Director
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 2, 2017 | M | 52,500 | $83.68 | A | 313,355 | D | |
| Common StockF3,F4 | Feb 2, 2017 | S | 43,207 | $117.7717 | D | 270,148 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $83.68 | Feb 2, 2017 | M | 52,500 | D | — | Feb 5, 2017 | Common Stock | 52,500 | 0 | D |
Explanation of responses
- F1Securities acquired pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- F2Includes 269 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017.
- F3Securities sold to cover option exercise cost, taxes and fess pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- F4Represents the sale of 43,207 shares in multiple transactions, ranging in price from $117.26 to $118.23 per share, resulting in a weighted average sale price of $117.7717. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F5Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.